| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ramez M Ali, Lina T Al Kury, Keun-Hang Susan Yang, Anwar Qureshi, Mohanraj Rajesh, Sehamuddin Galadari, Yaroslav M Shuba, Frank Christopher Howarth, Murat O. Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. Cell calcium. vol 57. issue 4. 2015-12-30. PMID:25711828. |
cannabidiol (cbd), a major nonpsychotropic cannabinoid found in cannabis plant, has been shown to influence cardiovascular functions under various physiological and pathological conditions. |
2015-12-30 |
2023-08-13 |
rat |
| Hardeep Chohan, Ariele L Greenfield, Vijayshree Yadav, Jennifer Grave. Use of Cannabinoids for Spasticity and Pain Management in MS. Current treatment options in neurology. vol 18. issue 1. 2015-12-26. PMID:26705757. |
use of cannabinoids for spasticity and pain management in ms. several randomized trials have demonstrated potential benefit of cannabis derivatives in the symptomatic treatment of multiple sclerosis (ms) patients. |
2015-12-26 |
2023-08-13 |
Not clear |
| Emily K Roberson, Walter K Patrick, Eric L Hurwit. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai'i. Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health. vol 73. issue 9. 2015-12-22. PMID:25285255. |
cannabinoid hyperemesis syndrome, which can cause severe nausea and vomiting in marijuana users, is another complicating factor. |
2015-12-22 |
2023-08-13 |
Not clear |
| Santiago Papini, Gregory M Sullivan, Denise A Hien, Erel Shvil, Yuval Neri. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research. Biological psychology. vol 104. 2015-12-17. PMID:25448242. |
despite the lack of clinical research, marijuana and synthetic cannabinoids have been approved to treat posttraumatic stress disorder (ptsd) in several states in the united states. |
2015-12-17 |
2023-08-13 |
human |
| István Katon. Cannabis and Endocannabinoid Signaling in Epilepsy. Handbook of experimental pharmacology. vol 231. 2015-12-16. PMID:26408165. |
cannabis and endocannabinoid signaling in epilepsy. |
2015-12-16 |
2023-08-13 |
Not clear |
| Angelo A Izzo, Giulio G Muccioli, Michael R Ruggieri, Rudolf Schich. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease. Handbook of experimental pharmacology. vol 231. 2015-12-16. PMID:26408170. |
drugs that inhibit endocannabinoid degradation and raise the level of endocannabinoids, non-psychotropic cannabinoids (notably cannabidiol), and palmitoylethanolamide, an acylethanolamide co-released with the endocannabinoid anandamide, are promising candidates for gastrointestinal and urinary diseases. |
2015-12-16 |
2023-08-13 |
Not clear |
| Chandni Hindocha, Tom P Freeman, Grainne Schafer, Chelsea Gardener, Ravi K Das, Celia J A Morgan, H Valerie Curra. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 25. issue 3. 2015-12-15. PMID:25534187. |
acute administration of the primary psychoactive constituent of cannabis, Δ-9-tetrahydrocannabinol (thc), impairs human facial affect recognition, implicating the endocannabinoid system in emotional processing. |
2015-12-15 |
2023-08-13 |
human |
| A Rahimi, M Faizi, F Talebi, F Noorbakhsh, F Kahrizi, N Nader. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice. Neuroscience. vol 290. 2015-12-15. PMID:25637488. |
among cannabinoid compounds, cannabidiol (cbd) and palmitoylethanolamide (pea) have no psychotropic activities. |
2015-12-15 |
2023-08-13 |
mouse |
| Charu Sharma, Bassem Sadek, Sameer N Goyal, Satyesh Sinha, Mohammad Amjad Kamal, Shreesh Ojh. Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development. Evidence-based complementary and alternative medicine : eCAM. vol 2015. 2015-12-15. PMID:26664449. |
the cannabinoid molecules are derived from cannabis sativa plant which acts on the cannabinoid receptors types 1 and 2 (cb1 and cb2) which have been explored as potential therapeutic targets for drug discovery and development. |
2015-12-15 |
2023-08-13 |
Not clear |
| Erman Öztürk, Alihan Oral, Melek Özdemir, Nail Bambu. Synthetic marijuana "K2" induced ITP. Platelets. vol 26. issue 3. 2015-12-14. PMID:24749892. |
k2 is synthetic marijuana which acts on cannabinoid receptors that are found on immune cells and thrombocytes. |
2015-12-14 |
2023-08-13 |
Not clear |
| Harshini Neelakantan, Ronald J Tallarida, Zachary W Reichenbach, Ronald F Tuma, Sara J Ward, Ellen A Walke. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behavioural pharmacology. vol 26. issue 3. 2015-12-08. PMID:25485642. |
the present study investigated the antinociceptive effects of the nonpsychoactive cannabinoid, cannabidiol (cbd) and the µ-opioid agonist morphine, both alone and in combination, using three behavioral models in mice, to test the hypothesis that combinations of morphine and cbd would produce synergistic effects. |
2015-12-08 |
2023-08-13 |
mouse |
| Benno Hartung, Silke Kauferstein, Stefanie Ritz-Timme, Thomas Daldru. Sudden unexpected death under acute influence of cannabis. Forensic science international. vol 237. 2015-11-24. PMID:24598271. |
the acute toxicity of cannabinoids is said to be low and there is little public awareness of the potentially hazardous cardiovascular effects of cannabis, e.g. |
2015-11-24 |
2023-08-12 |
Not clear |
| Bandana Chakravarti, Janani Ravi, Ramesh K Ganj. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. vol 5. issue 15. 2015-11-20. PMID:25115386. |
cannabinoids comprise of (a) the active compounds of the cannabis sativa plant, (b) endogenous as well as (c) synthetic cannabinoids. |
2015-11-20 |
2023-08-13 |
Not clear |
| Randall G Krug, Karl J Clar. Elucidating cannabinoid biology in zebrafish (Danio rerio). Gene. vol 570. issue 2. 2015-11-17. PMID:26192460. |
although exogenous cannabinoids, like those contained in marijuana, are known to exert their effects by disrupting the endocannabinoid system, a dearth of knowledge exists about the potential toxicological consequences on public health. |
2015-11-17 |
2023-08-13 |
zebrafish |
| Randall G Krug, Karl J Clar. Elucidating cannabinoid biology in zebrafish (Danio rerio). Gene. vol 570. issue 2. 2015-11-17. PMID:26192460. |
this provides the framework for a discussion of how zebrafish may be leveraged in the future to provide novel toxicological and therapeutic insights in the field of cannabinoid biology, which has become increasingly significant given recent trends in cannabis legislation. |
2015-11-17 |
2023-08-13 |
zebrafish |
| Nikolaos Raikos, Helene Schmid, Susanne Nussbaumer, Lars Ambach, Stephan Lanz, Andreas Längin, Stefan König, Nadine Roth, Volker Auwärter, Wolfgang Weinman. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. Forensic science international. vol 243. 2015-11-12. PMID:25173986. |
the detection of thca-a in biological fluids may serve as a marker for differentiating between the intake of prescribed thc medication - containing only pure thc - and cannabis products containing thc besides thc-acid a and other cannabinoids. |
2015-11-12 |
2023-08-13 |
human |
| Kevin P Hil. Medical marijuana: more questions than answers. Journal of psychiatric practice. vol 20. issue 5. 2015-11-09. PMID:25226202. |
the author discusses the medical literature on synthetic cannabinoids and medical marijuana. |
2015-11-09 |
2023-08-13 |
Not clear |
| X Muschart, J Flamen. A non-classical cannabinoid syndrome. Acta clinica Belgica. vol 70. issue 4. 2015-11-06. PMID:25567676. |
hyperemesis cannabinoid syndrome (hcs) is characterized by cyclic vomiting and compulsive bathing behaviors in chronic cannabis users. |
2015-11-06 |
2023-08-13 |
Not clear |
| John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwe. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. British journal of pharmacology. vol 172. issue 3. 2015-11-02. PMID:25257544. |
are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? |
2015-11-02 |
2023-08-13 |
Not clear |
| John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwe. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. British journal of pharmacology. vol 172. issue 3. 2015-11-02. PMID:25257544. |
based upon evidence that the therapeutic properties of cannabis preparations are not solely dependent upon the presence of Δ(9) -tetrahydrocannabinol (thc), pharmacological studies have been recently carried out with other plant cannabinoids (phytocannabinoids), particularly cannabidiol (cbd) and Δ(9) -tetrahydrocannabivarin (thcv). |
2015-11-02 |
2023-08-13 |
Not clear |